ISIN | IE000KPKZIB2 |
---|---|
Valor Number | 138622051 |
Bloomberg Global ID | WEFEGEA ID |
Fund Name | Wellington Management Funds (Ireland) plc - Wellington Focused European Equity Fund GBP E AccU |
Fund Provider |
Wellington Management Company LLP
Web: https://www.wellingtonfunds.com |
Fund Provider | Wellington Management Company LLP |
Representative in Switzerland |
BNP Paribas, Paris, Zurich Branch Zürich |
Distributor(s) | Wellington Global Administrator, Ltd. |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Ireland |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The investment objective of the Fund is to seek long-term total returns. The Investment Manager will actively manage the Fund, seeking to outperform the MSCI Europe Index (the "Index”) and achieve the objective primarily through investment in the equity and equity related securities of companies domiciled or operating primarily in developed European markets. |
Peculiarities |
Current Price * | 9.61 GBP | 23.12.2024 |
---|---|---|
Previous Price * | 9.59 GBP | 20.12.2024 |
52 Week High * | 10.17 GBP | 27.09.2024 |
52 Week Low * | 9.59 GBP | 20.12.2024 |
NAV * | 9.61 GBP | 23.12.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 4,762,814 | |
Unit/Share Assets *** | 7,392 | |
Trading Information SIX |
YTD Performance | - | - |
---|---|---|
YTD Performance (in CHF) | - | - |
1 month | -2.46% |
25.11.2024 - 23.12.2024
25.11.2024 23.12.2024 |
3 months | -5.52% |
27.09.2024 - 23.12.2024
27.09.2024 23.12.2024 |
6 months | - | - |
1 year | - | - |
2 years | - | - |
3 years | - | - |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 4.44% | |
---|---|---|
Tate & Lyle PLC | 3.97% | |
Compagnie de Saint-Gobain SA | 3.72% | |
Roche Holding AG | 3.39% | |
Siemens AG | 3.23% | |
Reckitt Benckiser Group PLC | 3.03% | |
ING Groep NV | 2.99% | |
Tesco PLC | 2.99% | |
Babcock International Group PLC | 2.92% | |
Koninklijke Philips NV | 2.91% | |
Last data update | 31.10.2024 |
TER | |
---|---|
TER date | |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.30% |
Ongoing Charges *** | 0.45% |
SRRI ***
|
|
SRRI date *** | 30.11.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |